U.S. Markets closed
  • S&P Futures

    4,281.75
    -4.75 (-0.11%)
     
  • Dow Futures

    33,961.00
    -20.00 (-0.06%)
     
  • Nasdaq Futures

    13,507.75
    -15.50 (-0.11%)
     
  • Russell 2000 Futures

    1,997.30
    -4.40 (-0.22%)
     
  • Crude Oil

    90.55
    +0.05 (+0.06%)
     
  • Gold

    1,769.80
    -1.40 (-0.08%)
     
  • Silver

    19.39
    -0.07 (-0.38%)
     
  • EUR/USD

    1.0082
    -0.0010 (-0.1008%)
     
  • 10-Yr Bond

    2.8800
    -0.0130 (-0.45%)
     
  • Vix

    19.56
    -0.34 (-1.71%)
     
  • GBP/USD

    1.1912
    -0.0021 (-0.1775%)
     
  • USD/JPY

    136.3170
    +0.4550 (+0.3349%)
     
  • BTC-USD

    22,984.31
    -343.29 (-1.47%)
     
  • CMC Crypto 200

    545.72
    -12.01 (-2.15%)
     
  • FTSE 100

    7,541.85
    +26.10 (+0.35%)
     
  • Nikkei 225

    29,075.43
    +133.29 (+0.46%)
     

Olink to present at the 40th Annual J.P. Morgan Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

UPPSALA, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced it will be virtually participating in the 40th Annual J.P. Morgan Healthcare Conference.

Jon Heimer, CEO, is scheduled to present on Wednesday, January 12th, 2022, at 9:00 am ET.

A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at https://investors.olink.com/investor-relations.

About Olink
Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The company was founded in 2016 and is well established across Europe, North America and Asia. Olink is headquartered in Uppsala, Sweden.

For more information please contact:

IR Contact
Jan Medina, CFA
VP Investor Relations & Capital Markets
Mobile: +1 617 802 4157
jan.medina@olink.com

Media Contact
Andrea Prander
Corporate Communications Manager
Mobile: + 46 768 775 275
andrea.prander@olink.com